av/pieris-pharmaceuticals--big.svg

COM:PIERIS

Pieris Pharmaceuticals, Inc.

  • Stock

Last Close

16.61

31/10 14:32

Market Cap

9.31M

Beta: -

Volume Today

573

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
9.88M
-
5.37M
45.70%
2.93M
45.35%
5.83M
98.87%
25.27M
333.48%
29.10M
15.14%
46.28M
59.03%
29.32M
36.64%
31.42M
7.14%
25.90M
17.56%
42.81M
65.28%
cost of revenue
55.00M
-
46.53M
15.39%
2.37M
94.91%
2.78M
17.40%
1.78M
35.94%
gross profit
12.43M
-
5.37M
56.83%
2.93M
45.35%
5.83M
98.87%
25.27M
333.48%
29.10M
15.14%
-8.72M
129.95%
-17.21M
97.41%
29.05M
268.82%
23.12M
20.41%
41.03M
77.45%
selling and marketing expenses
general and administrative expenses
2.46M
-
6.96M
182.86%
8.37M
20.18%
8.89M
6.25%
17.58M
97.78%
18.44M
4.88%
18.44M
0.01%
16.71M
9.37%
16.59M
0.72%
16.39M
1.20%
16.85M
2.80%
selling general and administrative expenses
2.46M
-
6.96M
182.86%
8.37M
20.18%
8.89M
6.25%
17.58M
97.78%
18.44M
4.88%
18.44M
0.01%
16.71M
9.37%
16.59M
0.72%
16.39M
1.20%
16.85M
2.80%
research and development expenses
9.41M
-
5.60M
40.50%
8.24M
47.22%
19.70M
138.93%
22.29M
13.13%
41.49M
86.18%
55.00M
32.55%
46.53M
15.39%
66.66M
43.25%
52.98M
20.51%
40.02M
24.46%
other expenses
6.31K
-
3.00K
52.40%
10.90K
263.26%
119.50K
995.84%
-2.10M
1,858.98%
1.80M
185.78%
-26K
101.44%
-3.66M
13,961.54%
-3.69M
0.79%
-8.17M
121.79%
13.91M
270.22%
cost and expenses
9.33M
-
12.56M
34.71%
16.61M
32.23%
28.59M
72.09%
39.87M
39.45%
59.93M
50.32%
73.44M
22.53%
63.24M
13.88%
79.56M
25.80%
61.20M
23.08%
58.65M
4.16%
operating expenses
9.33M
-
12.56M
34.71%
16.61M
32.23%
28.59M
72.09%
39.87M
39.45%
59.93M
50.32%
73.44M
22.53%
63.24M
13.88%
79.56M
25.80%
61.20M
23.08%
56.87M
7.07%
interest expense
493.94K
-
2.65M
437.46%
184.65K
93.04%
2.32K
98.74%
1.95M
83,951.72%
-3.77M
293.08%
-10.20M
-
ebitda
944.81K
-
-7.20M
861.56%
-13.67M
89.99%
-22.76M
66.49%
-14.22M
37.50%
-30.26M
112.73%
-26.12M
13.69%
-31.79M
21.74%
-48.15M
51.43%
-35.30M
26.68%
-14.06M
60.16%
operating income
553.83K
-
-7.20M
1,399.73%
-13.68M
90.06%
-22.76M
66.35%
-14.59M
35.88%
-30.83M
111.26%
-27.16M
11.92%
-33.92M
24.91%
-51.83M
52.80%
-43.47M
16.12%
-15.84M
63.56%
depreciation and amortization
384.68K
-
366.98K
4.60%
307.91K
16.10%
361.38K
17.37%
369K
2.11%
570K
54.47%
1.04M
82.46%
2.13M
104.52%
3.69M
73.25%
8.17M
121.79%
1.78M
78.21%
total other income expenses net
6.31K
-
3.00K
52.40%
10.90K
263.26%
119.50K
995.84%
-2.10M
1,858.98%
3.77M
279.12%
1.69M
55.17%
-3.15M
286.32%
6.09M
293.74%
10.20M
67.36%
-8.70M
185.31%
income before tax
66.20K
-
-9.85M
14,980.03%
-13.85M
40.66%
-22.64M
63.39%
-16.54M
26.92%
-27.07M
63.60%
-25.47M
5.90%
-37.07M
45.53%
-45.74M
23.40%
-33.28M
27.24%
-24.54M
26.25%
income tax expense
487.63K
-
-18
100.00%
203.87K
1,132,688.89%
161.97K
20.55%
1.10M
580.99%
-312K
128.29%
-1.71M
449.36%
164K
109.57%
-2.37M
1,546.34%
-2.02M
14.67%
net income
66.20K
-
-9.85M
14,980.00%
-14.06M
42.73%
-22.80M
62.17%
-17.65M
22.60%
-26.75M
51.61%
-23.75M
11.21%
-37.23M
56.72%
-43.37M
16.48%
-31.25M
27.93%
-24.54M
21.47%
weighted average shs out
13.86M
-
13.87M
0.06%
34.39M
147.92%
41.71M
21.28%
43.93M
5.32%
53.08M
20.83%
50.63M
4.63%
54.48M
7.62%
64.55M
18.48%
74.17M
14.91%
90.06M
21.43%
weighted average shs out dil
13.86M
-
13.87M
0.06%
34.39M
147.92%
41.71M
21.29%
43.93M
5.32%
53.08M
20.83%
50.63M
4.63%
54.48M
7.62%
64.55M
18.48%
74.17M
14.91%
90.06M
21.43%
eps
0.00
-
-0.71
14,891.67%
-0.41
42.25%
-0.55
34.15%
-0.40
27.27%
-0.50
25.00%
-0.47
6.00%
-0.68
44.68%
-0.67
1.47%
-0.42
37.31%
-0.27
35.71%
epsdiluted
0.00
-
-0.71
14,891.67%
-0.41
42.25%
-0.55
34.15%
-0.40
27.27%
-0.50
25.00%
-0.47
6.00%
-0.68
44.68%
-0.67
1.47%
-0.42
37.31%
-0.27
35.71%

All numbers in (except ratios and percentages)